Latest Cystic fibrosis Stories
New research in The FASEB Journal suggests that cigarette smoke interferes with the Cystic Fibrosis Transmembrane Conductance Regulator protein, leading to dry, sticky mucus and increased infections If you smoke cigarettes, you have more in common with someone who has cystic fibrosis than you think. A new research report appearing online in the FASEB Journal (http://www.fasebj.org) shows that smoking cigarettes affects the lungs in a way that is very similar to cystic fibrosis, a life...
Agile Sciences will collaborate with Dr. Richard Boucher, Director of the Cystic Fibrosis Center at the University of North Carolina, Chapel Hill Raleigh, NC (PRWEB) October 10, 2011 The National Institutes of Health (NIH) has awarded Agile Sciences a Phase I STTR Grant to evaluate the efficacy of Agile Sciences’ proprietary Agilyte™ anti-biofilm molecules for treating lung infections of cystic fibrosis patients. The molecules will be tested in a new model of chronic lung...
NEW ALBANY, Ohio, Sept. 26, 2011 /PRNewswire/ -- Save the date for October 8, 2011. That is when Commercial Vehicle Group, Inc, (CVG) will host it Second Annual Fall Car, Cycle and Truck Show. This year's event will be held at the CVG Corporate Headquarters, 7800 Walton Parkway, New Albany, OH, from 8:00 a.m. until 7:00 p.m. Proceeds from the show will benefit the Cystic Fibrosis Foundation of Central Ohio, as well as the Flying Horse Farms located in Mt. Gilead, OH. Last year's event...
Novartis donates 20,000 EURO to support the Cystic Fibrosis Worldwide Education program. In 2011 CFW will partner with thier member, CF Saudi Arabia to bring the first of its kind CF conference to the Middle East. (PRWEB) September 24, 2011 Novartis, a healthcare solutions company headquartered in Switzerland, has donated 20,000 EURO to Cystic Fibrosis Worldwide (CFW) education programs headed by Dr. Harry Heijerman. The Cystic Fibrosis Worldwide education team is comprised of seven top...
Surgery to correct gastroesophageal reflux disease, or GERD, can preserve lung function in patients with end-stage pulmonary disease both before and after transplantation, according to a new study from the University of Pittsburgh School of Medicine. The findings, published today in the Archives of Surgery, suggest that esophageal testing should be performed more frequently among these patients to determine if anti-reflux surgery is needed. Many end-stage lung disease patients,...
Cystic fibrosis (CF), a chronic disease that clogs the lungs and leads to life-threatening lung infections, is caused by a genetic defect in a chloride channel called cystic fibrosis transmembrane conductase regulator (CFTR). Although scientists do not fully understand how or why this defect occurs, a team of researchers at The Hospital for Sick Children (SickKids) in Toronto, Ontario, Canada has found a promising clue: a protein called ubiquitin ligase Nedd4L. In a study led by Daniela...
When researchers discovered the primary genetic defect that causes cystic fibrosis (CF) back in 1989, they opened up a new realm of research into treatment and a cure for the disease. Since then, scientists have been able to clone the defective gene and study its effects in animals. Now researchers at the University of North Carolina at Chapel Hill have developed a technique for observing the defects at work in human tissue donated by patients with CF. This technique has yielded an...
Major Health and Consumer Groups Concerned Individuals with Major Medical Conditions Are Especially Vulnerable to Medicaid Cuts State-Specific Reports Will Detail Numbers of Individuals with Cancer, Heart Disease, Stroke, Diabetes, and Chronic Lung Disease Who Depend on Medicaid for Treatment WASHINGTON, Sept. 14, 2011 /PRNewswire-USNewswire/ -- Many Americans battle such medical conditions as cancer, diabetes, chronic lung disease, heart disease, and stroke, but those individuals who rely...
BOSTON and PELHAM, N.H., Sept. 7, 2011 /PRNewswire/ -- The Steven J. Vertuccio Memorial Ride for Cystic Fibrosis, now in its sixth year, continues to raise the bar in exercise excellence. In 2010 The Adult Cystic Fibrosis (CF) Program at Children's Hospital Boston and Brigham and Women's Hospital kicked-off the Steven Vertuccio Wellness Program, designed to encourage patients to exercise during their hospitalizations and as outpatients in order to improve their conditioning and quality of...
SOUTH PLAINFIELD, N.J. and CAMBRIDGE, Mass., Sept. 2, 2011 /PRNewswire/ -- PTC Therapeutics, Inc. and Genzyme, a Sanofi company, announced today the restructuring of their collaboration. Under the original agreement, PTC held commercial rights for the U.S. and Canada and Genzyme held commercial rights in all other countries. Under the restructured agreement, PTC regains worldwide rights to ataluren and Genzyme retains an option to commercialize ataluren in indications other than nonsense...
